Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00181714
Status:
COMPLETED
Last Update Posted:
2013-05-07
First Post:
2005-09-13
Brief Title:
Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder ADHD Youth With Concerta
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Study Overview
Official Title:
Prevention of Cigarette Smoking in ADHD Youth With Concerta
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will consist of a six-week open-label treatment period with an extended duration methylphenidate OROS MPH followed by subsequent monthly visits for 24 months in a large sample of youths aged 12-17 who meet Diagnostic and Statistical Manual of Mental Disorders Fourth Edition DSM-IV criteria for ADHD
The researchers hypothesize that OROS MPH treatment will be associated with low rates of cigarette smoking in ADHD youth
The researchers hypothesize that OROS MPH treatment will be associated with low rates of cigarette smoking in ADHD youth
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None